Associated Papers
Impact of pharmacokinetic (CYP2C9) and pharmacodynamic (VKORC1, F7, GGCX, CALU, EPHX1) gene variants on the initiation and maintenance phases of phenprocoumon therapy.
Luxembourg B et al.
Thrombosis and Haemostasis, 2011
Select a paper to view details